Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Innovation and Growth at Actelion Ltd.
Pisano, Gary P.; Beyersdorfer, Daniela; Dittrich, RuthCaso HBS-611065-ELiderazgo y Dirección de personasIn late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on their orphan indication drug Tracleer, which Actelion sold and market...Desde 8,20 €
-
North Goes East
Retsinas, Nicolas P.; Beyersdorfer, Daniela; Corsi, ElenaCaso HBS-208136-EFinanzasIn August 2006, Magnus Lofgren and Robert Provine, managing directors and co-founders of the "North Real Estate Opportunities Fund," need to decide which real estate investment the Fund should pursue as its first project. The Fund's target region, Central and Eastern Europe, was changing rapidly and returns in some of the more developed regions started to resemble those generated in Western Europe. Yet, the two partners had managed to identify se...Desde 8,20 €
-
MorphoSys AG: The Evolution of a Biotechnology Business Model
Pisano, Gary P.; Johnson, Ryan; Knoop, Carin-IsabelCaso HBS-611046-EServicios y operacionesIn the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this profitability not by developing and selling its own drugs, but by licensing access to its proprietary library of human antibodies. Recently, the company decided to deviate from this model, and attempt to develop its own proprietary products. The case allows analysis of "license vs. vertically integrate" business model de...Desde 8,20 €
-
Marine Harvest: Leading Salmon Aquaculture
Bell, David E.; Johnson, RyanCaso HBS-512042-ETo maximize their effectiveness, color cases should be printed in color. Marine Harvest has the leading position in salmon aquaculture. Aquaculture is very much a growth business, many believing it could play a major role in solving the world's growing need for protein. The CEO is considering three alternatives for taking advantage of his firm's dominant position. Expand production in Chile, produce value-added salmon products, or backward-integr...Desde 8,20 €
-
Colgate-Palmolive: Staying Ahead in Oral Care
Henderson, Rebecca M.; Johnson, RyanCaso HBS-311120-EDirección estratégicaIn 2011, Colgate-Palmolive (Colgate) was the global leader in oral care, with a dominant market share lead in toothpaste and a growing presence in toothbrushes and mouthwash. However, the firm faced stiff competition with perennial rivals P&G increasing tDesde 8,20 €
-
Procter & Gamble: Marketing Capabilities
Henderson, Rebecca M.; Johnson, RyanCaso HBS-311117-EMarketingP&G had become known and recognized as a marketing machine. It was the largest advertiser in the world, with 2010 spending of $8.68 billion. From the company's early exploitation of broadcast media (radio and television) for its soap products to more receDesde 8,20 €
-
Danone: Changing the Food System
Bell, David E.; Gabrieli, Federica; Beyersdorfer, DanielaCaso HBS-520053-EMarketingEmmanuel Faber, Chairman and CEO of the food and beverage company Danone, believed that humankind had only ten years to bend the curve on climate change and restore the biodiversity that the global food and agricultural ecosystem was critically dependent on. Upon becoming CEO in 2014, he had built on Danone's long history of CSR-engagement to give a boost to the company's mission to bring health through food to as many people as possible. In Sept...Desde 8,20 €
-
La Ribera Health Department (A)
Herzlinger, Regina E.; Moloney, Emer; Beyersdorfer, DanielaCaso HBS-315006-EEconomíaWhat Business Model elements enabled La Ribera to achieve this level of value? How can it improve on its 1% profit margin and better align itself with the Six Factors? The hospital hired a consulting firm that presented four new options that could potentially increase returns. Which, if any, best fit with the ten elements of its Business Model? The B case (9-318-134) contains the d nouement for La Ribera.Desde 8,20 €
-
Procter & Gamble: capacidades de mercadeo
Henderson, Rebecca M.; Johnson, RyanCaso HBS-314S04MarketingP & G se había convertido en conocido y reconocido como una máquina de marketing. Fue el mayor anunciante en el mundo, con el año 2010 el gasto de $ 8,68 mil millones. Desde temprana explotación de la compañía de medios de difusión (radio y televisión) para sus productos de jabón a más recientes experimentos en los medios digitales para la marca de la higiene de sus hombres de Old Spice, P & G era un vendedor experimentado una fuerte investigació...Desde 8,20 €
-
L'Occitane en Provence
Becker, Bo; Beyersdorfer, Daniela; Mayfield, E. Scott; Yamazaki, MayukaCaso HBS-212051-EFinanzasCosmetics company L'Occitane en Provence must decide if it is the right time to go public, and, if so, where to list. The firm could list on Euronext in Paris, close to the firm's headquarters in southern France, on one of the large exchanges in the United States, or perhaps in Asia, where much of the firm's future growth is expected. The case provides opportunities to discuss the benefits and costs of going public, including valuation implicatio...Desde 8,20 €